Victents rose 15% from the IPO price on the first day of the transfer listing

Reporter Paul Lee / approved : 2023-08-18 01:27:24
  • -
  • +
  • 인쇄

 

[Apha Biz=(Chicago) Reporter Paul Lee] Shares of Victents, a drama production company, closed at a price higher than the initial public offering price on the 17th, the first day of its listing from KONEX to KOSDAQ, but it is said to have been sluggish considering the recent rise in stock prices on the day of the listing of public offering stocks.

On this day, Victents closed at 26,350 won, up 14.57% from the initial public offering price of 23,000 won. Victents, which was previously listed on the KOSDAQ market from KONEX on the same day, jumped to 45,700 won, more than 98.7% of the initial public offering price, but soon gave up an increase.

Considering the case in which the stock price of new incoming stocks soared more than twice the initial public offering price after the exchange eased the stock price fluctuation on the day of the listing, the Victents's increase was not significant. Big Tenz recorded a closing price of 32,550 won on the 16th, the last trading day of the KONEX market.

Victents's KONEX market price of 32,550 won was more than 30% higher than the public offering price of 23,000 won, so the public offering price was set as the standard price on the listing date.

Victents's sales and operating profit last year were 32.2 billion won and 1.7 billion won, respectively. Since it was incorporated as a subsidiary of F&F last year, business synergy effect is also expected. Attention is focusing on whether it will secure competitiveness in the content market based on the drama Intellectual Property Rights (IP).

 

Alphabiz Reporter Paul Lee(hoondork1977@alphabiz.co.kr)

주요기사

Civic Groups File Complaint Against Baemin and Coupang Eats Over Alleged Misleading “One-Person Free Delivery” Promotions2025.09.19
KT Confirms Additional Victims in Unauthorized Micro-Payment Case, Faces Criticism Over Initial Response2025.09.19
KFTC Grants Conditional Approval for Joint Venture Between Shinsegae Group and Alibaba Group2025.09.19
Supreme Court Rules in Favor of NTS on U.S. Unregistered Patent Royalties2025.09.19
Korea Zinc to Cancel All Treasury Shares by Year-End, Targeting Shareholder Return Ratio Above 200%2025.09.19
뉴스댓글 >

HEADLINE

건강이 보이는 대표 K Medical 뉴스

PHOTO

많이 본 기사